Engineered Cancer Exosomes (HLA‑G Targeted)
Cancer Immunotherapy
PreclinicalActive
Key Facts
About Esco Aster
Integrated CDMO delivering cGMP‑grade vaccines, cell‑therapies and cultivated meat via proprietary packed‑bed bioreactors.
View full company profileTherapeutic Areas
Other Cancer Immunotherapy Drugs
| Drug | Company | Phase |
|---|---|---|
| CYTER915 | FibroBiologics | Discovery |
| Immuno-Oncology | Resolve Biosciences | Research-Use |
| In vivo CAR-T Program | Deliver Biosciences | Pre-clinical |
| Novel Target Discovery | Noetik | Discovery |